Skip to main content

Part of Cancer staging guidance sheets

Appendix (ICD10 C18.1)

Current Chapter

Current chapter – Appendix (ICD10 C18.1)


Introduction

This is the data sheet for TNM 9th edition staging of the appendix (ICD10 C18.1).

For more detailed information regarding TNM staging, please see pages 72-74 of the UICC TNM 9 book.


Stage groupings

Stage Group

T stage

N stage

M stage

Grade

Stage 0

Tis

N0

M0

 

Stage 0

Tis (LAMN)

N0

M0

 

Stage I

T1, T2

N0

M0

 

Stage IIA

T3

N0

M0

 

Stage IIB

T4a

N0

M0

 

Stage IIC

T4b

N0

M0

 

Stage IIIA

T1, T2

N1

M0

 

Stage IIIB

T3, T4

N1

M0

 

Stage IIIC

Any T

N2

M0

 

Stage IVA

Any T

Any N

M1a

Any G

 

Any T

Any N

M1b

G1

Stage IVB

Any T

Any N

M1b

G2, G3, GX

Stage IVC

Any T

Any N

M1c

Any G


TNM clinical classification

T - primary tumour

T value

Description

cTX

Primary tumour cannot be assessed

cT0

No evidence of primary tumour

cTis

Carcinoma in situ: intraepithelial or invasion of lamina propria

cTis (LAMN)a

Low‐grade appendiceal mucinous neoplasm confined to the muscolaris propria; acellular mucin or mucinous epithelium may invade muscularis propria

cT1

Tumour invades submucosab

cT2

Tumour invades muscularis propriab

cT3

Tumour invades subserosa or mesoappendix

cT4

Tumour perforates visceral peritoneum, including mucinous peritoneal tumour or acellular mucin on the serosa of the appendix or mesoappendix and/or directly invades other organs or structuresc

cT4a - Tumour perforates visceral peritoneum, including mucinous peritoneal tumour or acellular mucin on the serosa of the appendix or mesoappendix

cT4b - Tumour directly invades other organs or structures

Note

aThe Tis(LAMN) category does not apply HAMNs; HAMN are staged using the appendiceal adenocarcinoma T categories

bT1 and T2 are not applicable to LAMN; acellular mucin or mucinous epithelium that extends into the subserosa or serosa should be classified as T3 or T4a, respectively 

cDirect invasion in T4 includes invasion of other intestinal segments by way of the serosa, e.g. invasion of ileum. Tumour that is adherent to other organs or structures, macroscopically, is classified as cT4b. However, if no tumour is present in the adhesion, microscopically, the classification should be pT1, 2 or 3

N - regional lymph nodes

N value

Description

cNX

Regional lymph nodes cannot be assessed

cN0

No regional lymph node metastasis

cN1

Metastasis in 1 to 3 regional lymph nodes

 

cN1a - Metastases in 1 regional lymph node

cN1b - Metastases in 2–3 regional lymph nodes

cN1c - Tumour deposit(s), i.e. satellites,* in the subserosa, or in non‐peritonealized pericolic or perirectal soft tissue without regional lymph node metastasis

cN2

Metastasis in 4 or more regional lymph nodes

Note

* Tumour deposits (TDs) represent discrete tumour nodules of any shape, contour or size in peri-rectal and peri-colonic fat, away from the leading edge of the tumour, within the lymph drainage area of the primary carcinoma. TDs can originate from different histological structures, including lymph nodes, vessels and nerves. Therefore, TDs may contain foci of extramural vascular invasion (EMVI) and perineural invasion (PNI). The feature distinguishing a TD from EMVI and PNI is the presence of unequivocal tumour extension from the vessel or nerve into the surrounding fat or fibroconnective tissue. When tumour outgrowth from EMVI and/or PNI is present, the diagnosis of TDs and EMVI/PNI should be denoted separately in the report. If the tumour involves an identifiable lymph node, it is considered as lymph node metastasis and not as TDs even if the tumour extends into the perinodal fat.

M - distant metastasis

M value

Description

cM0

No distant metastasis

cM1

Distant Metastasis

cM1a - Intraperitoneal acellular mucin only

cM1b - Intraperitoneal metastasis only, including mucinous epithelium

cM1c - Non‐peritoneal metastasis


TNM pathological classification

pT - primary tumour

The pT and pN categories correspond to the cT and cN categories as per above.

pN - regional lymph nodes

pN value

Description

pN0

Histological examination of a regional lymphadenectomy specimen will ordinarily include 12 or more lymph nodes. If the lymph nodes are negative, but the number ordinarily examined is not met, classify as pN0


Download

Click on the box below to download a PDF version of this staging sheet:

Last edited: 16 January 2026 3:56 pm

  1. Cancer staging guidance sheets
  2. Oral Cavity and mucosal lip (ICD10 C00.3-5, C02-C06)
  3. Malignant melanoma of upper aerodigestive tract (ICD10 C00-06, C09-14, C30-32)
  4. Pharynx (ICD10 C01, C02.4, C05.1-2, C09, C10.0, C10.2-3, C10.9, C11-13)
  5. Salivary glands (ICD10 C00-C14, C15.0, C30-C33, C41.1)
  6. Oesophagus including oesophagogastric junction (ICD10 C15, C16.0)
  7. Gastrointestinal stromal tumours (ICD10 C15-C20, C48.1-2)
  8. Stomach (ICD10 C16 - excluding C16.0)
  9. Small intestine (ICD10 C17)
  10. Appendix (ICD10 C18.1)
  11. Colon and rectum (ICD10 C18-C20)
  12. Anal and perianal skin (ICD10 C21)
  13. Liver (ICD10 C22.0)
  14. Intrahepatic bile ducts (ICD10 C22.1)
  15. Gallbladder (ICD10 C23)
  16. Distal extrahepatic bile duct (ICD10 C24.0)
  17. Perihilar bile ducts (ICD10 C24.0)
  18. Ampulla of vater (ICD10 C24.1)
  19. Pancreas (ICD10 C25)
  20. Nasal cavity and paranasal sinuses (ICD10 C30.0, C31.0, C31.1)
  21. Larynx (ICD10 C32.0, C32.1, C32.2, C10.1)
  22. Lung (ICD10 C34)
  23. Thymus tumours (ICD10 C37.9)
  24. Soft tissues (ICD10 C15-C26, C34-C37 C38.1-3, C47-C49, C51-C53, C58, C60-C68)
  25. Bone (ICD10 C40, C41)
  26. Melanoma of skin (ICD10 C00.0-2, C00.6, C21.2, C43, C51, C60, C63.2)
  27. Merkel cell carcinoma of skin (ICD10 C00, C44, C51, C60, 63.2, C80)
  28. Skin carcinoma of the head and neck (ICD10 C00.0-2, C00.6, C44.0, C44.2-4)
  29. Carcinoma of skin of the eyelid (ICD10 C44.1)
  30. Carcinoma of skin (excluding eyelid, head and neck, perianal, vulva and penis) (ICD10 C44.5-7, C63.2)
  31. Pleural mesothelioma (ICD10 C38.4)
  32. Breast tumours (ICD10 C50)
  33. Vulva (ICD10 C51)
  34. Vagina (ICD10 C52)
  35. Cervix uteri (ICD10 C53)
  36. Uterine sarcomas
  37. Uterus - endometrium (ICD10 C54.1, C55)
  38. Ovarian, fallopian tube and primary peritoneal carcinoma (ICD10 C56, C57, C48.1, C48.2)
  39. Gestational trophoblastic neoplasms (ICD10 C58)
  40. Penis tumours (ICD10 C60)
  41. Prostate tumours (ICD10 C61.9)
  42. Testis tumours (ICD10 C62)
  43. Kidney tumours (ICD10 C64)
  44. Renal pelvis and ureter tumours (ICD10 C65 & C66)
  45. Urinary bladder tumours (ICD10 C67)
  46. Urethra tumours (ICD10 C68.0, C61.9)
  47. Carcinoma of conjuctiva (ICD10 C69.0)
  48. Melanoma of conjuctiva (ICD10 C69.0)
  49. Retinoblastoma (ICD10 C69.2)
  50. Melanoma of uvea (ICD10 C69.3-4)
  51. Carcinoma of lacrimal gland (ICD10 C69.5)
  52. Sarcoma of orbit (ICD10 C69.6)
  53. Thyroid gland (ICD10 C73.9)
  54. Adrenal cortex (ICD10 C74.0)
  55. Adrenal medulla and extra-adrenal paraganglia (ICD10 C74.1 C75.5)
  56. Parathyroid gland (ICD10 C75.0)
  57. Unknown primary - cervical nodes (ICD10 C77.0)
  58. Mycosis fungoides or sezary syndrome (ICD10 C84.0 and C84.1)
  59. T and B cutaneous lymphoma (ICD10, C82.6, C84.8, C86.6 and other C83-C86 if primary skin excluding C84.0 C84.1)
  60. Rhabdomyosarcoma (CTYA)
  61. Chronic lymphocytic leukaemia
  62. Hepatoblastoma (CTYA)
  63. Hodgkins and non-hodgkins lymphoma (ICD10 C81-88)
  64. Medulloblastoma
  65. Multiple myeloma
  66. Neuroblastoma
  67. Neuroendocrine tumours of the foregut
  68. Neuroendocrine tumours of the midgut and hindgut
  69. Non-hodgkin lymphoma (children)
  70. Wilms tumour of the kidney